CCL2 and CXCL2 are markers of delirium vulnerability in community dwelling older people
CCL2 und CXCL2 sind Marker für Delir-Anfälligkeit bei älteren Menschen in der Gemeinde
Age and Ageing · 04.09.2026 · 55 (9)
DOI: 10.1093/ageing/afag290 ↗Auf einen Blick
Bei älteren, in der Gemeinde lebenden Menschen waren CCL2 und CXCL2 zu Studienbeginn bei Personen mit späterem Delir höher als bei Personen ohne Delir. Die Analyse basierte auf der 2-jährigen Nachbeobachtung.
Fragestellung
Sind Marker der Immunzellmigration, des beschleunigten Immunalterns und der Blut-Hirn-Schranken-Permeabilität mit späterem Delir bei älteren Menschen assoziiert?
Methode
Basismessungen aus CASCADE; 2 Jahre Follow-up mit wöchentlichem Delir-Screening und Delirbeurteilung bei positivem Screening oder Krankenhausaufnahme; Serum-Analyse per Multiplex-Panel.
Ergebnisse
Etwa 98 Teilnehmende; Medianalter 88 Jahre, 90,8 % frail. 43 Teilnehmende (43,9 %) hatten ≥1 Delirepisode. CCL2: 13,38 vs. 10,83, P=.004; CXCL2: 17,23 vs. 13,49, P=.031.
Schlussfolgerung der Autor:innen
CCL2 und CXCL2 waren mit Delir assoziiert und könnten Marker eines beschleunigten Immunalterns sein. Weitere Arbeiten sollen die Rolle von Immunzellrekrutierung und Gehirninfiltration klären.
Kernaussagen
- CCL2 und CXCL2 waren bei späterem Delir zu Studienbeginn höher
- 43,9 % erlebten ≥1 Delirepisode innerhalb von 2 Jahren
- Befunde waren bei CCL2 auch nach Demenzstatus konsistent
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 30.09.2026. Verfasst von Hannah Moorey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inflammation and Ageing, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK. Hauptthemen laut MEDLINE: Delirium, Chemokine CCL2, Chemokine CXCL2, Independent Living. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Geriatric Society and Vivensa Foundation.
Themen: Gerontologische Pflege, Delir
Abstract (Originalsprache)
Background
Delirium is common and age, frailty and dementia are risk-factors. The pathophysiology is complex and poorly understood, but age-related immune system changes may be key. This study aimed to measure markers of immune cell migration, accelerated immune ageing and blood–brain barrier permeability in community-dwelling, older people comparing those who developed ≥1 episode of delirium over 2 years with those that did not.
Methods
Baseline samples were collected from CASCADE participants who were followed up for 2 years. Delirium screening was performed weekly; positive screens or hospital admission triggered a delirium assessment. Serum was isolated, stored and analysed using a multiplex panel comparing levels between participants with and without delirium episodes.
Results
About 98 participants were included. Median age was 88 (IQR: 81.8–92.0), with 90.8% classified as frail. Forty-three participants (43.9%) experienced ≥1 delirium episodes. CCL2 (MCP-1) and CXCL2 (MIP-2α), measured in a stable state at baseline, were significantly higher in the delirium group compared to the no delirium group (13.38 (11.21–17.93) vs. 10.83 (9.03–14.64) P = .004) and (17.23 (11.80–24.22) vs. 13.49 (10.19–17.98) P = .031), respectively. When stratified by dementia status, the associations of CCL2 with delirium were maintained in both groups, but CXCL2 was only significantly higher in delirium in the subgroup without dementia.
Discussion
CCL2 and CXCL2 are chemokines involved in immune cell recruitment and markers of accelerated immune ageing. Future work should elucidate the role of immune cell recruitment and brain infiltration in delirium, to identify treatment targets. Furthermore, work should explore whether targeting immune ageing can reduce delirium risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Inflammation and Ageing, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK.
- Oslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
- Old Age Psychiatry Research Network, Telemark Hospital Trust, Skien, Norway.
- Department of Medical Biochemistry, Vestfold Hospital Trust, Tønsberg, Norway.
- Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
- Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
ORCID-Profile: Daisy Wilson, Thomas Andrew Jackson
Förderung
- British Geriatric Society and Vivensa Foundation
Zitieren
APA
Moorey, H., Botfield, H. F., Krogseth, M., Selbaek, G., Wilson, D., Wyller, T. B., & Jackson, T. A. (2026). CCL2 and CXCL2 are markers of delirium vulnerability in community dwelling older people. Age and Ageing, 55(9). https://doi.org/10.1093/ageing/afag290
Vancouver
Moorey H, Botfield HF, Krogseth M, Selbaek G, Wilson D, Wyller TB, et al. CCL2 and CXCL2 are markers of delirium vulnerability in community dwelling older people. Age and Ageing. 2026;55(9). doi:10.1093/ageing/afag290
BibTeX
@article{Moorey2026,
author = {Moorey, Hannah and Botfield, Hannah F and Krogseth, Maria and Selbaek, Geir and Wilson, Daisy and Wyller, Torgeir Bruun and Jackson, Thomas Andrew},
title = {CCL2 and CXCL2 are markers of delirium vulnerability in community dwelling older people},
journal = {Age and Ageing},
year = {2026},
volume = {55},
number = {9},
doi = {10.1093/ageing/afag290}
}
EUVIMED